Supplemental Figure 3 from Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors
0Citations signalées
0Institutions associées
0Pays d’affiliation
Résumé fourni par la source
Tumor mutational burden and diagnosed Lynch syndrome in patients with MSI-high status determined by only one method
Sujets associés
Genetic factors in colorectal cancerCancer Immunotherapy and BiomarkersMultiple and Secondary Primary Cancers